Impact of an Early vs Timely Diagnosis of Dementia: Data from the UK DETERMIND cohort

Date/Time
Date(s) - 28/11/2024
2:00 pm - 3:00 pm

November 28th 2024 at 2:00pm-3:00pm ET

Register for the seminar here: https://shorturl.at/naLEQ 

Dr. Ben Hicks is a Senior Research fellow based at the Brighton and Sussex Medical School (BSMS) in England. For the past 5 years he has been Programme Manager for DETERMIND; a multimillion pound ESRC/ NIHR funded prospective cohort that examines and addresses inequalities and inequities in the post-diagnostic dementia care pathway. Within the role he leads a
workstream examining the experiences and impact of an early vs late and timely vs untimely diagnosis of dementia on the well-being and life quality of people living with dementia and their
care partners

*****

Global Policy directives seeking to support people to live well with dementia often advocate an “early” or “timely” diagnosis. Although modelling studies suggest and early diagnosis may be beneficial for families and societies by preventing or delaying admissions to hospitals or care homes, there is a limited quantitative evidence that gathers insights from people with dementia and their carers. This talk will draw on baseline data collected as part of the DETERMIND study. This prospective cohort consists of 930 newly diagnosed people with dementia and 700 carers from socially and geographically diverse areas of England, UK, who completed comprehensive questionnaires convening their experiences of the post-diagnostic care journey and the impact on their well-being and life quality. Dr. Hicks will discuss his initial analysis that provides first insights into the sociodemographic determinants that may result in an early vs late and timely vs untimely
diagnosis as well as the potential associations diagnosistic timing has for the well-being and life quality of newly diagnosed people with dementia and their carers.